RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.
1994
Antagonists Pharmaceutical Policy Mifepristone
No items found
Try changing the filters